Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Flail Chest-II01:26

Flail Chest-II

Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of a prior hypercapnia experience on recognition of hypercapnia in divers: a randomised controlled study.

Diving and hyperbaric medicine·2026
Same author

Arterial blood gas changes in progressively deeper breath-hold dives.

Journal of applied physiology (Bethesda, Md. : 1985)·2026
Same author

Hyperbaric oxygen therapy for acute idiopathic sudden sensorineural hearing loss; a systematic review with meta-analysis.

Diving and hyperbaric medicine·2025
Same author

Do opportunities exist to improve the use of the WHO Surgical Safety Checklist in cardiology and cardiothoracic surgery? Perspectives of patients and staff in a multimethod study in New Zealand.

BMJ open·2025
Same author

Revised guideline for central nervous system oxygen toxicity exposure limits when using an inspired PO2 of 1.3 atmospheres.

Diving and hyperbaric medicine·2025
Same author

Hyperbaric oxygen therapy for late onset dropped head syndrome following mantle field radiation therapy for Hodgkin lymphoma: a case report and literature review.

Diving and hyperbaric medicine·2025
Same journal

Interventions to prevent or cease electronic cigarette use in children and adolescents.

The Cochrane database of systematic reviews·2026
Same journal

Drugs to improve anaemia, quality of life, and physical function in people with myelodysplastic syndromes (MDS).

The Cochrane database of systematic reviews·2026
Same journal

Interventions for smoking cessation in inpatient psychiatry settings.

The Cochrane database of systematic reviews·2026
Same journal

Mechanical thromboprophylaxis for preventing intradialytic hypotension in people undergoing maintenance haemodialysis.

The Cochrane database of systematic reviews·2026
Same journal

Prognostic models for predicting intensive care unit admission or mortality in critically ill adults not yet been admitted to the intensive care unit.

The Cochrane database of systematic reviews·2026
Same journal

Views and experiences of weight management for people living with mobility‑limiting conditions, intellectual disabilities or severe mental illness: a qualitative evidence synthesis.

The Cochrane database of systematic reviews·2026
See all related articles

Related Experiment Video

Updated: May 22, 2026

Full-Endoscopic Interlaminar Approach for Decompression of Lateral Recess Stenosis
02:02

Full-Endoscopic Interlaminar Approach for Decompression of Lateral Recess Stenosis

Published on: February 24, 2023

Recompression and adjunctive therapy for decompression illness.

Michael H Bennett1, Jan P Lehm, Simon J Mitchell

  • 1Department of Anaesthesia, Prince ofWales Hospital, Randwick, Australia. m.bennett@unsw.edu.au

The Cochrane Database of Systematic Reviews
|May 18, 2012
PubMed
Summary
This summary is machine-generated.

Recompression therapy is standard for decompression illness (DCI), but lacks RCT evidence. Adjunctive therapies like NSAIDs or heliox may reduce recompression frequency but do not improve recovery odds.

More Related Videos

A Suture Technique for Ruptured Annulus Fibrosus Following Decompression Under Percutaneous Transforaminal Endoscopic Discectomy
03:24

A Suture Technique for Ruptured Annulus Fibrosus Following Decompression Under Percutaneous Transforaminal Endoscopic Discectomy

Published on: January 26, 2024

Related Experiment Videos

Last Updated: May 22, 2026

Full-Endoscopic Interlaminar Approach for Decompression of Lateral Recess Stenosis
02:02

Full-Endoscopic Interlaminar Approach for Decompression of Lateral Recess Stenosis

Published on: February 24, 2023

A Suture Technique for Ruptured Annulus Fibrosus Following Decompression Under Percutaneous Transforaminal Endoscopic Discectomy
03:24

A Suture Technique for Ruptured Annulus Fibrosus Following Decompression Under Percutaneous Transforaminal Endoscopic Discectomy

Published on: January 26, 2024

Area of Science:

  • Hyperbaric Medicine
  • Diving Physiology
  • Emergency Medicine

Background:

  • Decompression illness (DCI) results from bubble formation after breathing compressed gas.
  • DCI can range from mild symptoms to severe outcomes like paralysis or death.
  • Recompression is the established treatment for DCI, with strategies to improve outcomes for delayed treatment.

Purpose of the Study:

  • To evaluate the effectiveness and safety of recompression and adjunctive therapies for DCI treatment.
  • To synthesize evidence from randomized controlled trials (RCTs) on DCI management.

Main Methods:

  • Systematic search of multiple databases (CENTRAL, MEDLINE, CINAHL, EMBASE) up to October 2011.
  • Inclusion of randomized controlled trials comparing recompression schedules or adjunctive therapies against standard treatment.
  • Independent data extraction and validity assessment by three authors.

Main Results:

  • Two RCTs with 268 patients met inclusion criteria; one had unclear risk of bias, the other low risk.
  • Non-steroidal anti-inflammatory drugs (NSAIDs) did not improve effectiveness but reduced required recompressions.
  • Helium-oxygen (heliox) breathing tables showed lower odds of multiple recompressions compared to oxygen tables.

Conclusions:

  • Recompression therapy lacks RCT evidence despite being standard care for DCI.
  • NSAIDs and heliox may decrease recompression frequency but do not enhance recovery.
  • Further large, rigorous RCTs are needed to clarify benefits of different breathing gases and pressure profiles.